A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis

Journal of Bone and Joint Surgery

Volumn 91, Issue 5, 2009, Pages 1190-1198

  Masi, L ^a   Gozzini, A ^a   Franchi, A ^a   Campanacci, D ^a   Amedei, A ^a   Falchetti, A ^a   Franceschelli, F ^a   Marcucci, G ^a   Tanini, A ^a   Capanna, R ^a   Brandi, M L ^a  

^a University Hospital of Florence   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; GENOMIC DNA; N ACETYLGALACTOSAMINYLTRANSFERASE; PHOSPHORUS; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ADULT; ARTICLE; CALCIFICATION; CASE REPORT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; HYPERPHOSPHATEMIA; MALE; PEDIGREE ANALYSIS; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SHOULDER; TUMOR CALCINOSIS;

AGED; CALCINOSIS; FEMALE; FIBROBLAST GROWTH FACTORS; GENES, RECESSIVE; HUMANS; HYPERPHOSPHATEMIA; MALE; MIDDLE AGED; MUTATION; N-ACETYLGALACTOSAMINYLTRANSFERASES; PEDIGREE; PHOSPHATES;

EID: 69549150986     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.H.00783     Document Type: Article

References (35)

1. Neuman W. Bone material and calcification mechanisms. In: Urist MR, editor. Fundamental and clinical bone physiology. Philadelphia: Lippincott; 1980. p 83-107.
2. Berndt TJ, Schiavi S, Kumar RK. "Phosphatonins" and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol. 2005;289:F1170-82.
3. Schiavi SC, Moe OW. Phosphatonins: a new class of phosphate-regulating proteins. Curr Opin Nephrol Hypertens. 2002;11:423-430 (Pubitemid 34734622)
4. Econs MJ, Drezner MK. Tumor-induced osteomalacia-unveiling a new hormone. N Engl J Med. 1994;330:1679-1681
5. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int. 2004;65:1-14. (Pubitemid 38037486)
6. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuci Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561-568 (Pubitemid 38542505)
7. Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Jüppner H, Jonsson KB. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology. 2004;145:3087-3094
8. Econs MJ, McEnery PT, Lennon F, Speer MC. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest. 1997;100:2653-2657 (Pubitemid 28007531)
9. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutation in FGF23. Nat Genet. 2000;26:345-348
10. Chefetz I, Heller R, Galli-Tsinopoulou A, Richard G, Wollnik B, Indelman M, Koerber F, Topaz O, Bergman R, Sprecher E, Schoenau E. A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification. Hum Genet. 2005;118:261-266 (Pubitemid 41672088)
11. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet. 2004;36:579-581 (Pubitemid 38715983)
12. Ichikawa S, Lyles KW, Econs MJ. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab. 2005;90:2420-2423 (Pubitemid 40590063)
13. Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab. 2005;90:2424-2427 (Pubitemid 40586293)
14. Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab. 2005;90:5523-5527 (Pubitemid 41415453)
15. National Center for Biotechnology Information. Single nucleotide polymorphism. http://www.ncbi.nlm.nih.gov/SNP/. Accessed 2006 May 25.
16. Software License: Copyright (c) 1999-2008. The European Bioinformatics Institute and Genome Research Limited, and others. Variations in ENST00000237837. http://www.ensembl.org/Homo-sapinets/genesnpview. Ensembl release 50 - Jul 2008. Accessed 2008 Sept.
17. Kneller D. NNPredict: protein secondary structure prediction. The University of California, San Francisco. http://www.cmpharm.ucsf.edu/;nomi/ nnpredict.html. Accessed 2008 Sept.
18. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med. 1994;330:1645-1649 (Pubitemid 24166865)
19. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003;348:1656-1663 (Pubitemid 36459471)
20. Mannstadt H, Lorente C, Jüppner H. Rapid detection of intact FGF-23 in tumor tissue from patients with oncogenic osteomalacia [letter]. Clin Chem. 2008;54:7-9. (Pubitemid 352009709)
21. Razzaque MS, Lanske B. The emerging role of the fibroblast growth factor-23- klotho axis in renal regulation of phosphate homeostasis. J Endocrinology. 2007;194:1-10. (Pubitemid 47162881)
22. Ichikawa S, Imel EA, Kreiter ML, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest. 2007;117:2684-2691 (Pubitemid 47494368)
23. Specktor P, Cooper JG, Indelman M, Sprecher E. Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred. J Hum Genet. 2006;51:487-490 (Pubitemid 43863787)
24. Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet. 2005;14:385-390 (Pubitemid 40220655)
25. Larsson T, Davis SI, Garringer HJ, Mooney SD, Draman MS, Cullen MJ, White KE. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology. 2005;146:3883-3891 (Pubitemid 41178968)
26. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992;358:761-764
27. Fukuda T, Kanomata K, Nojima J, Urakawa I, Suzawa T, Imada M, Kukita A, Kamijo R, Yanashita T, Katagiri T. FGF23 induces expression of two isoforms of NAB2 which are corepressors of Egr-1. Biochem Biophys Res Commun. 2007;353:147-151 (Pubitemid 44958353)
28. Takeda E, Yamamoto H, Nashiki K, Sato T, Arai H, Taketani Y. Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med. 2004;8:191-200. (Pubitemid 44145508)
29. Burnett SM, Gunawardene S, Bringhurst FR, Jüppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21:1187-1196 (Pubitemid 44128331)
30. Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90:1519-1524 (Pubitemid 40464013)
31. Burnett SM, Gunawardene SC, Bringhurst FR, Jüppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res. 2006;21:1187-1195 (Pubitemid 44128331)
32. Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005;289:G1036-42.
33. Drissi H, Pouliot A, Koolloos C, Stein JL, Lian JB, Stein GS, van Wijnen AJ. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp Cell Res. 2002;274:323-333
34. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007;115:377-386 (Pubitemid 46148512)
35. Shanahan CM. Inflammation ushers in calcification: a cycle of damage and protection? Circulation. 2007;116:2782-2785